Treatment of pulmonary exacerbations in cystic fibrosis - could do better?

被引：4
|
作者：
Smyth, Alan [1 ]
机构：
[1] Univ Nottingham, Sch Med, Nottingham NG7 2RD, England
来源：
PAEDIATRIC RESPIRATORY REVIEWS | 2016年 / 20卷
关键词：
Cystic fibrosis; Pulmonary exacerbations; Symptom score; Microbiome; Adverse effects of antibiotics; ACUTE-RENAL-FAILURE; TOBRAMYCIN; UK;
D O I：
10.1016/j.prrv.2016.06.004
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
This article describes the nature and significance of pulmonary exacerbations in cystic fibrosis (CF). The effectiveness and safety of current exacerbation treatment are explored. The article concludes with a summary of clinical trials (completed and ongoing) which aim to improve the efficacy and safety of exacerbation treatment. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [21] Role of hyperglycemia in cystic fibrosis pulmonary exacerbations
    Merjaneh, Lina
    Sidhaye, Aniket R.
    Vu, Phuong T.
    Heltshe, Sonya L.
    Goss, Christopher H.
    Flume, Patrick A.
    Kelly, Andrea
    Rosenfeld, Margaret
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (05) : 868 - 874
  • [22] Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status
    Range, SP
    Dunster, C
    Knox, AJ
    Kelly, FJ
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (03) : 560 - 564
  • [23] Reevaluating approaches to cystic fibrosis pulmonary exacerbations
    不详
    PEDIATRIC PULMONOLOGY, 2018, 53 : S51 - S63
  • [24] Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
    Asner, Sandra
    Waters, Valerie
    Solomon, Melinda
    Yau, Yvonne
    Richardson, Susan E.
    Grasemann, Hartmut
    Gharabaghi, Farhad
    Tran, Dat
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (05) : 433 - 439
  • [25] Location and Duration of Treatment of Cystic Fibrosis Respiratory Exacerbations Do Not Affect Outcomes
    Collaco, J. Michael
    Green, Deanna M.
    Cutting, Garry R.
    Naughton, Kathleen M.
    Mogayzel, Peter J., Jr.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (09) : 1137 - 1143
  • [26] Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995-2005
    VanDevanter, Donald R.
    Elkin, Eric P.
    Pasta, David J.
    Morgan, Wayne J.
    Konstan, Michael W.
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (04) : 332 - 337
  • [27] Preferred health outcome states following treatment for pulmonary exacerbations of cystic fibrosis
    McLeod, Charlie
    Wood, Jamie
    Mulrennan, Siobhain
    Morey, Sue
    Schultz, Andre
    Messer, Mitch
    Spaapen, Kate
    Wu, Yue
    Mascaro, Steven
    Smyth, Alan R.
    Blyth, Christopher C.
    Webb, Steve
    Snelling, Thomas L.
    Norman, Richard
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (04) : 581 - 587
  • [28] Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults
    Esquivel, Marc D.
    Monogue, Marguerite L.
    Smith, Greg S.
    Finklea, James D.
    Sanders, James M.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 28 : 67 - 70
  • [29] Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis
    Wagener, Jeffrey S.
    Williams, Michael J.
    Millar, Stefanie J.
    Morgan, Wayne J.
    Pasta, David J.
    Konstan, Michael W.
    JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (04) : 496 - 502
  • [30] Pulmonary exacerbations in cystic fibrosis: Young children with characteristic signs and symptoms
    Regelmann, Warren E.
    Schechter, Michael S.
    Wagener, Jeffrey S.
    Morgan, Wayne J.
    Pasta, David J.
    Elkin, Eric P.
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2013, 48 (07) : 649 - 657
12345